Abstract-The contents of [Met5]-enkephalin and its four hydrolysis products, Tyr, Tyr-Gly, Tyr-Gly-Gly, and Tyr-Gly-Gly-Phe, in the sample obtained after enke phalin was incubated with tissues in either the absence or the presence of the peptidase inhibitor were estimated by high performance liquid chromatography combined with electrochemical detection in order to elucidate the effect of the peptidase inhibitor on enkephalin hydrolysis.
Abstract-The contents of [Met5]-enkephalin and its four hydrolysis products, Tyr, Tyr-Gly, Tyr-Gly-Gly, and Tyr-Gly-Gly-Phe, in the sample obtained after enke phalin was incubated with tissues in either the absence or the presence of the peptidase inhibitor were estimated by high performance liquid chromatography combined with electrochemical detection in order to elucidate the effect of the peptidase inhibitor on enkephalin hydrolysis.
Free Tyr was the major degradative product in the absence of the peptidase inhibitor, while the major hydrolysis product was the Tyr-Gly-Gly fragment in the presence of amastatin in both total homoge nates and membrane fractions prepared from either the myenteric plexus-longitudinal muscle strip of guinea-pig ileum or the striatum of guinea-pig brain. Additionally, captopril significantly decreased the generation of Tyr-Gly-Gly in the presence of amastatin in both ileal and striatal membrane fractions. Moreover, thiorphan significantly prevented the formation of Tyr-Gly-Gly in the presence of both amastatin and captopril in both membrane preparations.
Finally, when [Met5]-enkephalin was incubated with either an ileal or a striatal membrane fraction for 60 min at 37 °C in the presence of three peptidase inhibitors, amastatin, captopril, and thiorphan, approximately 98 or 94%, respectively, of enkephalin remained intact.
The results indicated that [Met5]-enkephalin was almost exclusively hydrolyzed by three distinct enzymes, amastatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A, and thiorphan-sensitive endopeptidase-24.1 1 in both ileal and striatal membrane fractions. Preparation of total homogenates and membrane fractions from guinea-pig ileum and brain: Male Hartley guinea-pigs weighing 700-900 g were used for this study. The myenteric plexus-longitudinal muscle strip of guinea-pig ileum was prepared as described previously (4) . The striatum of guinea-pig brain was dissected by the method of Glowinski and Iversen (5) . After either the strips or the striata were cut to small pieces with scissors in 50 mM Tris-HCI buffer, pH 7.4, they were homogenized in 15 volumes of the above buffer with a Teflon-glass homogenizer.
The homogenate was diluted with the buffer to a concentration of 2 mg/ml of protein, yielding the sample employed in the following experiment as a total homogenate.
A 3% homogenate of either the myenteric plexus-longitudinal muscle strip of guinea-pig ileum or the striatum of guinea-pig brain was prepared in 50 mM Tris-HCI buffer, pH 7.4, with a Teflon-glass homogenizer and centrifuged at 800 x g for 15 min. The super natant was collected. The pellet was resus pended with 5 ml of the above buffer, and the suspension was centrifuged again at 800xg for 15 min. The supernatant was combined with the initial supernatant.
The combined supernatant was centrifuged at 49,000xg for 10 min. The resulting pellet was washed 3 times by suspension in the buffer and centrifugation.
The washed pellet was sus pended and adjusted with the buffer to a concentration of 2 mg/ml of protein, yielding the sample used in the following experiment as a membrane fraction.
Protein concentrations were measured by the method of Lowry et al. (6) enkephalin for 60 min at 37°C in a total volume of 0.5 ml, followed by the addition of 0.5 ml of 10% TCA and centrifugation at 3,000 rpm for 1 5 min. The chromatographic mobile phase was 0.1 M phos phate buffer at pH 3.0 containing 5% acetonitrile in A and C and phosphate buffer containing 25% acetonitrile in B and D at the flow rate of 0.8 ml/min. The ECD worked at an applied voltage of 1 V versus the Ag/AgCI reference electrode. 1, Tyr; 2, Tyr-Gly Gly; 3, Tyr-Gly; 4, Tyr-Gly-Gly-Phe; and 5, [MetS] Enkephalin. moto MFG. Co., Ltd.,) and an ECD (VM D 101) (Yanagimoto MFG. Co., Ltd.). The chromatographic mobile phase was 0.1 M phosphate buffer at pH 3.0 containing 5% acetonitrile for Tyr, Tyr-Gly and Tyr-Gly-Gly assays (Fig. 1A) and that containing 25% acetonitrile for Tyr-Gly-Gly-Phe and [Met5] enkephalin assays (Fig. 1 B) . at the flow rate of 0.8 ml/min. The ECD worked at an applied voltage of 1 V versus the Ag/AgCI reference electrode. Under these conditions, Tyr, Tyr Gly, Tyr-Gly-Gly, Tyr-Gly-Gly-Phe, or [Met5] enkephalin exhibited a retention time of approximately 5.5, 9, 7, 5, or 8 min, respec tively (Figs. 1A and 1 B), and the detection limit of each compound was approximately 2 pmol. The recovery of [Met5]-enkephalin and its hydrolysis products added to the boiled homogenate or membrane fraction was above 95%. Therefore, the content of each compound was estimated not by correcting with the % of its recovery.
Calculations: The content of each com pound was determined by comparison of the peak heights in the sample and standard. Working standards were run at regular intervals to check the sensitivity of the detector. Tyr was always detected even when the sample of either a total homogenate or a membrane fraction was incubated in the absence of [Met5]-enkephalin ( either an ileal or a striatal membrane fraction could not be estimated 60 min after the incubation ( Figs. 2A and 2B) .
The magnitude of the free Tyr generation in an ileal membrane fraction was higher than that in a striatal membrane fraction at any time of the estimation from 15 to 60 min after the incubation (Figs. 2A and 2B). In contrast to the Tyr formation, the magnitude of the production of the Tyr-Gly-Gly fragment in an ilea) membrane fraction was lower than that in a striatal membrane fraction ( Figs. 2A  and 2B ). This implied that the enzyme activity producing the free Tyr relative to that releasing the Tyr-Gly-Gly fragment in an ileal preparation was higher than that in a striatal preparation.
Since [Met5]-enkephalin was wholly hydrolyzed during the 60 min incubation with both ileal and striatal membrane fractions, the effect of the peptidase inhibitor on the enkephalin hydrolysis was examined by the 60 min incubation in the following experi ments.
Effects was wholly converted to Tyr during the incubation with an ileal total homogenate when the incubation mixture did not contain the peptidase inhibitor or con tained either captopril or thiorphan. When the incubation mixture contained puromycin (1 mM), however, the Tyr peak height was decreased; and instead, three additional peaks corresponding to Tyr-Gly-Gly, Tyr-Gly-Gly Phe and [Met5]-enkephalin appeared (Table [Met5]-Enkephalin (5 nmol) was incubated in 50 mM Tris-HCI buffer at pH 7.4 with a total homogenate (0.5 mg of protein) of guinea-pig ileum in either the absence or the presence of the peptidase inhibitor for 60 min at 37'C in a total volume of 0.5 ml. The incubation was terminated by the addition of TCA. After centrifugation, a sample (10-20 ul) of the supernatant was analyzed by HPLC-ECD to assess the product formation as described in Marterials and Methods. The content of each compound was deter mined by comparison of the peak heights in the sample and standard.
Results were expressed as the % content of each compound against the amount of [Met5]-enkephalin added to the incubation mixture initially. Each value represents the mean±S.E. of 3 determinations. 1). This implied that the enkephalin hydrolyzing aminopeptidase was partially inhibited by puromycin, and an ileal total homogenate also contained enzymes pro ducing the Tyr-Gly-Gly and Tyr-Gly-Gly-Phe fragments. When the reaction mixture con tained amastatin (1 ,vM), on the other hand, five monitored compounds were all detected, suggesting that an ileal total homogenate contained not only enzymes releasing Tyr, Tyr-Gly-Gly and Tyr-Gly-Gly-Phe but also the peptidase producing the Tyr-Gly frag ment. Additionally, the results obtained by using puromycin and amastatin showed that the magnitude of the inhibition of the enkephalin-hydrolyzing aminopeptidase by amastatin (1 /tM) was significantly higher than that by puromycin (1 nM) (Table 1) . Moreover, the results showed that the major degradative product in an ileal total homogenate was Tyr-Gly-Gly when the aminopeptidase was inhibited. Effects of peptidase inhibitors on the hydrolysis of [Met5] -enkephalin incubated with an ileal membrane fraction: Like the results obtained with an ileal total homoge nate, a free Tyr peak alone was detected in the sample obtained after [Met5]-enkephalin (5 nmol) was incubated with a membrane fraction (0.5 mg of protein) of the myenteric plexus-longitudinal muscle strip of guinea pig ileum in the absence of the peptidase inhibitor or the presence of either captopril (1 aM) or thiorphan (1 jiM) for 60 min at 37'C in a total volume of 0.5 ml (Table 2) . In contrast to the results obtained with a total homogenate, however, when [Met5] enkephalin was incubated with an ileal membrane fraction, a free Tyr peak was only slightly decreased by puromycin (1 mM) but completely disappeared by treatment with amastatin (1 ,oM) ( Table 2) . Additionally, the degree of the free Tyr production in the presence of puromycin in a membrane fraction was significantly higher than that in a total homogenate (Tables 1 and 2 ), indicating that the aminopeptidase in a total homogenate was more susceptible to puro mycin than that in a membrane fraction. Moreover, a Tyr-Gly peak could not be detected when [Met5] -enkephalin was incubated with a membrane fraction even in the presence of either amastatin alone, two peptidase inhibitors, amastatin, and captopril, or three peptidase inhibitors, amastatin, captopril, and thiorphan ( Table 2 ), indicating that in contrast to a total homogenate, an ileal membrane fraction did not significantly contain the enzyme releasing the Tyr-Gly fragment from [Met5]-enkephalin. Further more, the magnitude of the Tyr-Gly-Gly generation in the presence of amastatin in a membrane fraction was significantly higher than that in a total homogenate (Tables 1 and   Table 2 . Effects of peptidase inhibitors on the hydrolysis of [Met5]-enkephalin incubated with a mem brane fraction of guinea-pig ileum
[Met5]-Enkephalin (5 nmol) was incubated in 50 mM Tris-HCI buffer at pH 7.4 with a membrane fraction (0.5 mg of protein) of guinea-pig ileum in either the absence or the presence of the peptidase inhibitor for 60 min at 37'C in a total volume of 0.5 ml. The incubation was terminated by the addition of TCA. After centrifugation, a sample (10-20 frl) of the supernatant was analyzed by HPLC-ECD to assess the product formation as described in Materials and Methods. The content of each compound was deter mined by comparison of the peak heights in the sample and standard.
Results were expressed as the % content of each compound against the amount of [Met5]-enkephalin added to the incubation mixture initially. Each value represents the mean+S.E. of 3 determinations.
2), suggesting that the enzyme activity releasing the Tyr-Gly-Gly fragment per mg of protein in a membrane fraction was higher than that in a total homogenate. The activity of aminopeptidase, however, was likely to be significantly higher than that of the enzyme releasing Tyr-Gly-Gly even in a membrane fraction since a free Tyr peak alone was detected in the absence of the peptidase inhibitor. When the incubation mixture con tained both amastatin and captopril, the Tyr Gly-Gly production was decreased when compared with the data in the presence of amastatin alone ( were detected in the sample obtained after [Met5]-enkephalin (5 nmol) was incubated with a total homogenate (0.5 mg of protein) of guinea-pig striatum in the absence of the peptidase inhibitor or in the presence of either captopril (1 W) or thiorphan (1 W) for 60 min at 37'C in a total volume of 0.5 ml (Table 3) . When the incubation mixture contained puromycin (1 mM), the content of free Tyr was decreased and instead that of both a Tyr-Gly and a Tyr-Gly-Gly fragment were increased (Table  3) . Additionally, when the incubation mixture contained amastatin (1 jtM), the amount of free Tyr was further decreased and instead that of both a Tyr-Gly and a Tyr-Gly Gly fragment were further increased (Table  3) . In contrast to the results obtained with ileal preparations (Tables 1 and 2 ), a Tyr-Gly Gly-Phe peak was not detected in the sample obtained from the incubation mixture con taining a striatal total homogenate in the presence of the aminopeptidase inhibitor (Table 3) . Additionally, in the presence of amastatin, the % production of the Tyr-Gly fragment in a striatal total homogenate was higher than that in an Heal total homogenate. [Met5]-Enkephalin (5 nmol) was incubated in 50 mM Tris-HCI buffer at pH 7.4 with a total homogenate (0.5 mg of protein) of guinea-pig striatum in either the absence or the presence of the peptidase inhibitor for 60 min at 37°C in a total volume of 0.5 ml. The incubation was terminated by the addition of TCA. After centrifugation, a sample (10-20 ul) of the supernatant was analyzed by HPLC-ECD to assess the product formation as described in Materials and Methods. The content of each compound was deter mined by comparison of the peak heights in the sample and standard.
Results were expressed as the % content of each compound against the amount of [Met5]-enkephalin added to the incubation mixture initially. Each value represents the mean±S.E. of 3 determinations. Table 4 . Effects of peptidase inhibitors on the hydrolysis of [Met5]-enkephalin incubated with a mem brane fraction of guinea-pig striatum [Me t5]-Enkephalin (5 nmol) was incubated in 50 mM Tris-HCI buffer at pH 7.4 with a membrane fraction (0.5 mg of protein) of guinea-pig striatum in either the absence or the presence of the peptidase inhibitor for 60 min at 37°C in a total volume of 0.5 m!. The incubation was terminated by the addition of TCA. After centrifugation, a sample (10-20 ul) of the supernatant was analyzed by HPLC-ECD to assess the product formation as described in Materials and Methods. The content of each compound was deter mined by comparison of the peak heights in the sample and standard.
Results were expressed as the % content of each compound against the amount of [Met5]-enkephalin added to the incubation mixture initially. Each value represents the mean±S.E. of 3 determinations.
These results showed that the activity per mg of protein of the enzyme releasing the Tyr-Gly fragment relative to that producing the Tyr Gly-Gly-Phe fragment in a striatal total homogenate was significantly higher than that in an ileal total homogenate.
Effects of peptidase inhibitors on the hydrolysis of [Met5]-enkephalin incubated with a striatal membrane fraction: I n contrast to the results obtained with a striatal total homogenate, only two peaks among five monitored compounds, a peak of free Tyr and that of the Tyr-Gly-Gly fragment, were detected in the sample obtained after [Met5] enkephalin (5 nmol) was incubated with a membrane fraction (0.5 mg of protein) of guinea-pig striatum in either the absence of the peptidase inhibitor or the presence of thiorphan (1 i M) for 60 min at 37°C in a total volume of 0.5 ml (Table 4) . When the incubation mixture contained either puromycin (1 mM) or amastatin (1 W), the content of free Tyr was decreased, but instead that of the Tyr-Gly-Gly fragment was increased (Table 4) . When the incubation mixture contained thiorphan, conversely, the content of the Tyr-Gly-Gly fragment was decreased, but instead that of free Tyr was increased ( Table 4 ). The % production of the Tyr-Gly-Gly fragment in the presence of both amastatin and captopril was significantly lower than that in the presence of amastatin alone ( Table 4 ), suggesting that the captopril sensitive peptidase was partially concerned with the production of the Tyr-Gly-Gly fragment. When the incubation mixture con tained three peptidase inhibitors, amastatin, captopril, and thiorphan, approximately 94% of [Met5]-enkephalin were not hydrolyzed during the incubation with a striatal mem brane fraction for 60 min at 37°C (Table 4) . Additionally, the sum of the % production of Tyr-Gly and that of Tyr-Gly-Gly-Phe was less than 5% in the presence of three peptidase inhibitors ( or a membrane fraction prepared from either guinea-pig striatum or the myenteric plexus-longitudinal muscle strip of guinea-pig ileum in either the absence or the presence of the peptidase inhibitor.
The major hydrolysis product of [Met5] enkephalin in the absence of the peptidase inhibitor is shown to be the free Tyr in all preparations employed in the present study. The observation that the % inhibition of the Tyr production by puromycin is approximately 70% in an ileal total homogenate, 5% in an ileal membrane fraction, 48% in a striatal total homogenate, and 57% in a striatal membrane fraction shows the presence of plural enkephalin-hydrolyzing aminopep tidases, the enzymes releasing the free Tyr, in terms of the sensitivity to puromycin. Additionally, the fact that puromycin has a quite low ability to inhibit the enkephalin hydrolyzing aminopeptidase in an ileal mem brane fraction supports the previous finding (1, 7) that the inhibitory potency of enkephalin in guinea-pig ileum is not enhanced by puromycin, since the mem brane-bound aminopeptidase must be more correlated than the soluble one to the potency of the exogenously given enkephalin (1). Moreover, the finding that puromycin has a significant inhibitory action on the enkephalin hydrolyzing aminopeptidase in striatal pre parations is consistent with the result reported previously (8) . It is noteworthy that the difference exists between the enkephalin hydrolyzing aminopeptidase in a striatal membrane fraction and that in an ileal membrane fraction in terms of the sensitivity to puromycin, since the membrane-bound aminopeptidase must be more important than the soluble one to terminate the action of both the enkephalin released from the presynaptic nerve terminal and that added exogenously.
This interesting observation suggests the presence of some structural differences between the enzyme in a striatal and an ileal membrane fraction. In fact, the structure of phosphoram1don-sensitive endo peptidase-24.11, another enkephalin-hydro lyzing peptidase, in the kidney has been reported to be slightly different from either that in the intestine (9) or that in the brain (10) . In contrast to puromycin, amastatin is found to have a quite potent inhibitory action on all enkephalin-hydrolyzing amino peptidases existing in the four preparations employed in the present study, being con sistent with the previous finding that amastatin significantly enhances the enkephalin-induced inhibition of the con tractions of guinea-pig ileum (1) .
The fact that the % production of Tyr-Gly in total homogenates is higher than that in membrane fractions prepared from both ileum and striatum implies that the enzyme releasing the Tyr-Gly fragment must be a soluble one and may not be correlated to the inactivation of both synaptically released and exogenously added enkephalin. The result obtained in the present study supports the previous report (1 ) that L-tyrosyl-L-tyrosine, an inhibitor of an amino-terminal-directed dipeptidylpeptidase (enkephalinase B) (11), does not significantly enhance the inhibition of the contractions of guinea-pig ileum produced by [Met5] enkephalin.
However, the present result is inconsistent with the report (12) that solubilized membrane fractions of rat brain contain the activity of enkephalinase B which generates the Tyr-Gly fragment from [Leu5] enkephalin. The cause of the disagreement existing between these two reports is not apparent at present.
The major degradative product of [Met5] enkephalin in the presence of amastatin, an aminopeptidase inhibitor, is found to be the Tyr-Gly-Gly fragment in all preparations used in the present investigation.
In contrast to the generation of Tyr-Gly, the production of the Tyr-Gly-Gly fragment is more marked in membrane fractions than total homogenates. The observation that the % production of Tyr Gly-Gly in the presence of both amastatin and captopril is significantly lower than that in the presence of amastatin alone indicates that the captopril-sensitive peptidyl dipep tidase A is partially concerned with the production of Tyr-Gly-Gly, being consistent with both the finding obtained by using a membrane fraction prepared from the electric organ of Torpedo marmorata (13) and the previous reports that captopril significantly augments the enkephalin-induced inhibition of contractions of both guinea-pig ileum (1) and mouse vas deferens (2) . Additionally, the fact that the % generation of the Tyr-Gly-Gly fragment in the presence of three peptidase inhibitors, amastatin, captopril, and thiorphan, is significantly lower than that in the presence of two peptidase inhibitors, amastatin, and captopril, suggests that thiorphan-sensitive endopeptidase-24.11 also partially correlates to the generation of the Tyr-Gly-Gly fragment, being consistent with both the report that thiorphan in the incubation medium increases the recovered amount of enkephalin released from the brain slice by K+-induced depolari zation (14) and the previous results that thiorphan enhances the inhibitory potency of enkephalin in both guinea-pig ileum (1) and mouse vas deferens (2) . Moreover, the fact that the production of Tyr-Gly-Gly is almost wholly inhibited in the presence of both captopril and thiorphan implies that another peptidase other than the two enzymes captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase 24.11 is not significantly involved in the generation of the Tyr-Gly-Gly fragment. Approximately 14% of [Met5]-enkephalin is found to be converted to Tyr-Gly-Gly-Phe in an ileal total homogenate containing amastatin.
In the membrane fractions, however, the % generation of this fragment is less than 4% in any of the incubation con ditions employed in the present study, indicating that the enzyme releasing Tyr Gly-Gly-Phe plays a quite minor role, if any, in the potency of both synaptically released and exogenously
given 
